novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
Published 2 years ago • 301 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
4:11
novel therapies and combinations for myelofibrosis patients
-
2:41
novel therapies for myelofibrosis
-
3:23
novel drugs and treatment strategies for myelofibrosis
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
2:05
adore: novel combinations with ruxolitinib for myelofibrosis
-
2:00
novel treatment strategies in myelofibrosis
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
2:44
myelofibrosis: jenson shares his experience
-
45:36
panel discussion | marketing 2.0 conference
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
3:56
an update on manifest: pelabresib monotherapy or as add-on to ruxolitinib in myelofibrosis
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
6:38
novel approaches for mpns
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:03:11
management of myelofibrosis: jak inhibitors and novel therapeutics in the peri-transplant setting
-
2:29
krt-232: a novel mdm2 inhibitor approach in myelofibrosis
-
3:19
finding novel targets for myelofibrosis from animal models
-
1:30
lcl161 for primary myelofibrosis: a new therapy in the field